Cargando…
Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland
BACKGROUND: We investigated the phenotypes and genotypes of a cohort of ‘long-surviving’ individuals with motor neuron disease (MND) to identify potential targets for prognostication. METHODS: Patients were recruited via the Clinical Audit Research and Evaluation for MND (CARE-MND) platform, which h...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971124/ https://www.ncbi.nlm.nih.gov/pubmed/36515702 http://dx.doi.org/10.1007/s00415-022-11505-0 |
_version_ | 1784898043106033664 |
---|---|
author | Leighton, Danielle J. Ansari, Morad Newton, Judith Parry, David Cleary, Elaine Colville, Shuna Stephenson, Laura Larraz, Juan Johnson, Micheala Beswick, Emily Wong, Michael Gregory, Jenna Carod Artal, Javier Davenport, Richard Duncan, Callum Morrison, Ian Smith, Colin Swingler, Robert Deary, Ian J. Porteous, Mary Aitman, Timothy J. Chandran, Siddharthan Gorrie, George H. Pal, Suvankar |
author_facet | Leighton, Danielle J. Ansari, Morad Newton, Judith Parry, David Cleary, Elaine Colville, Shuna Stephenson, Laura Larraz, Juan Johnson, Micheala Beswick, Emily Wong, Michael Gregory, Jenna Carod Artal, Javier Davenport, Richard Duncan, Callum Morrison, Ian Smith, Colin Swingler, Robert Deary, Ian J. Porteous, Mary Aitman, Timothy J. Chandran, Siddharthan Gorrie, George H. Pal, Suvankar |
author_sort | Leighton, Danielle J. |
collection | PubMed |
description | BACKGROUND: We investigated the phenotypes and genotypes of a cohort of ‘long-surviving’ individuals with motor neuron disease (MND) to identify potential targets for prognostication. METHODS: Patients were recruited via the Clinical Audit Research and Evaluation for MND (CARE-MND) platform, which hosts the Scottish MND Register. Long survival was defined as > 8 years from diagnosis. 11 phenotypic variables were analysed. Whole genome sequencing (WGS) was performed and variants within 49 MND-associated genes examined. Each individual was screened for C9orf72 repeat expansions. Data from ancestry-matched Scottish populations (the Lothian Birth Cohorts) were used as controls. RESULTS: 58 long survivors were identified. Median survival from diagnosis was 15.5 years. Long survivors were significantly younger at onset and diagnosis than incident patients and had a significantly longer diagnostic delay. 42% had the MND subtype of primary lateral sclerosis (PLS). WGS was performed in 46 individuals: 14 (30.4%) had a potentially pathogenic variant. 4 carried the known SOD1 p.(Ile114Thr) variant. Significant variants in FIG4, hnRNPA2B1, SETX, SQSTM1, TAF15, and VAPB were detected. 2 individuals had a variant in the SPAST gene suggesting phenotypic overlap with hereditary spastic paraplegia (HSP). No long survivors had pathogenic C9orf72 repeat expansions. CONCLUSIONS: Long survivors are characterised by younger age at onset, increased prevalence of PLS and longer diagnostic delay. Genetic analysis in this cohort has improved our understanding of the phenotypes associated with the SOD1 variant p.(Ile114Thr). Our findings confirm that pathogenic expansion of C9orf72 is likely a poor prognostic marker. Genetic screening using targeted MND and/or HSP panels should be considered in those with long survival, or early-onset slowly progressive disease, to improve diagnostic accuracy and aid prognostication. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-022-11505-0. |
format | Online Article Text |
id | pubmed-9971124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-99711242023-03-01 Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland Leighton, Danielle J. Ansari, Morad Newton, Judith Parry, David Cleary, Elaine Colville, Shuna Stephenson, Laura Larraz, Juan Johnson, Micheala Beswick, Emily Wong, Michael Gregory, Jenna Carod Artal, Javier Davenport, Richard Duncan, Callum Morrison, Ian Smith, Colin Swingler, Robert Deary, Ian J. Porteous, Mary Aitman, Timothy J. Chandran, Siddharthan Gorrie, George H. Pal, Suvankar J Neurol Original Communication BACKGROUND: We investigated the phenotypes and genotypes of a cohort of ‘long-surviving’ individuals with motor neuron disease (MND) to identify potential targets for prognostication. METHODS: Patients were recruited via the Clinical Audit Research and Evaluation for MND (CARE-MND) platform, which hosts the Scottish MND Register. Long survival was defined as > 8 years from diagnosis. 11 phenotypic variables were analysed. Whole genome sequencing (WGS) was performed and variants within 49 MND-associated genes examined. Each individual was screened for C9orf72 repeat expansions. Data from ancestry-matched Scottish populations (the Lothian Birth Cohorts) were used as controls. RESULTS: 58 long survivors were identified. Median survival from diagnosis was 15.5 years. Long survivors were significantly younger at onset and diagnosis than incident patients and had a significantly longer diagnostic delay. 42% had the MND subtype of primary lateral sclerosis (PLS). WGS was performed in 46 individuals: 14 (30.4%) had a potentially pathogenic variant. 4 carried the known SOD1 p.(Ile114Thr) variant. Significant variants in FIG4, hnRNPA2B1, SETX, SQSTM1, TAF15, and VAPB were detected. 2 individuals had a variant in the SPAST gene suggesting phenotypic overlap with hereditary spastic paraplegia (HSP). No long survivors had pathogenic C9orf72 repeat expansions. CONCLUSIONS: Long survivors are characterised by younger age at onset, increased prevalence of PLS and longer diagnostic delay. Genetic analysis in this cohort has improved our understanding of the phenotypes associated with the SOD1 variant p.(Ile114Thr). Our findings confirm that pathogenic expansion of C9orf72 is likely a poor prognostic marker. Genetic screening using targeted MND and/or HSP panels should be considered in those with long survival, or early-onset slowly progressive disease, to improve diagnostic accuracy and aid prognostication. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-022-11505-0. Springer Berlin Heidelberg 2022-12-14 2023 /pmc/articles/PMC9971124/ /pubmed/36515702 http://dx.doi.org/10.1007/s00415-022-11505-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Communication Leighton, Danielle J. Ansari, Morad Newton, Judith Parry, David Cleary, Elaine Colville, Shuna Stephenson, Laura Larraz, Juan Johnson, Micheala Beswick, Emily Wong, Michael Gregory, Jenna Carod Artal, Javier Davenport, Richard Duncan, Callum Morrison, Ian Smith, Colin Swingler, Robert Deary, Ian J. Porteous, Mary Aitman, Timothy J. Chandran, Siddharthan Gorrie, George H. Pal, Suvankar Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland |
title | Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland |
title_full | Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland |
title_fullStr | Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland |
title_full_unstemmed | Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland |
title_short | Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland |
title_sort | genotype–phenotype characterisation of long survivors with motor neuron disease in scotland |
topic | Original Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971124/ https://www.ncbi.nlm.nih.gov/pubmed/36515702 http://dx.doi.org/10.1007/s00415-022-11505-0 |
work_keys_str_mv | AT leightondaniellej genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT ansarimorad genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT newtonjudith genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT parrydavid genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT clearyelaine genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT colvilleshuna genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT stephensonlaura genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT larrazjuan genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT johnsonmicheala genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT beswickemily genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT wongmichael genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT gregoryjenna genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT carodartaljavier genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT davenportrichard genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT duncancallum genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT morrisonian genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT smithcolin genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT swinglerrobert genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT dearyianj genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT porteousmary genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT aitmantimothyj genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT chandransiddharthan genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT gorriegeorgeh genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT palsuvankar genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland AT genotypephenotypecharacterisationoflongsurvivorswithmotorneurondiseaseinscotland |